Get the Stockscreener App
22.59
0.48%
-0.11
After Hours:
22.59
Lifemd Inc stock is traded at $22.59, with a volume of 412.
It is down -0.48% in the last 24 hours and up +2.03% over the past month.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
See More
Previous Close:
$22.70
Open:
$22.6857
24h Volume:
412
Relative Volume:
0.22
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.99%
1M Performance:
+2.03%
6M Performance:
+3.15%
1Y Performance:
+22.17%
1-Day Range:
$22.59
$22.69
1-Week Range:
$21.82
$22.75
52-Week Range:
$17.15
$25.00
Lifemd Inc Stock (LFMDP) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
866 351 5907
Address
236 Fifth Avenue, Suite 400, New York
Compare LFMDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMDP
Lifemd Inc
|
22.59 | 0 | 0 | 0 | 0 | 0.00 |
|
WBA
Walgreens Boots Alliance Inc
|
9.02 | 7.80B | 147.66B | -8.64B | -363.00M | -10.01 |
|
HITI
High Tide Inc
|
3.26 | 263.01M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
4.63 | 95.67M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
SCNX
Scienture Holdings Inc
|
7.35 | 58.26M | 0 | 0 | 0 | 0.00 |
|
CJJD
China Jo Jo Drugstores Inc
|
2.0142 | 12.44M | 148.81M | -21.14M | 0 | -0.9969 |
Lifemd Inc Stock (LFMDP) Latest News
Trend Tracker for (LFMD) - Stock Traders Daily
Trend Tracker for (LFMDP) - Stock Traders Daily
Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) Price Target at $12.00 - MarketBeat
(LFMD) Technical Data - Stock Traders Daily
Royce & Associates LP Boosts Stock Holdings in LifeMD, Inc. (NASDAQ:LFMD) - MarketBeat
LifeMD (NASDAQ:LFMDP) Stock Price Down 1.1% – Should You Sell? - Defense World
LifeMD, Inc. (NASDAQ:LFMD) Shares Bought by Los Angeles Capital Management LLC - MarketBeat
LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMDP Stock News - StockTitan
LifeMD to Participate in Three Investor Conferences During November - The Manila Times
LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMD Stock News - StockTitan
LifeMD Inc (NASDAQ: LFMD) Could Pass $12 In One Year Stock Forecast - Stocks Register
HC Wainwright Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat
LifeMD, Inc. (NASDAQ:LFMD) Q3 2024 Earnings Call Transcript - Insider Monkey
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story - Simply Wall St
LifeMD Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
(LFMD) Technical Pivots with Risk Controls - Stock Traders Daily
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Teleh - GuruFocus.com
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD, Inc. (LFMD) Reports Q3 Loss, Lags Revenue Estimates - MSN
LifeMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
LifeMD Reports Third Quarter 2024 Results - The Manila Times
LifeMD earnings beat by $0.21, revenue fell short of estimates - Investing.com UK
Institutions profited after LifeMD, Inc.'s (NASDAQ:LFMD) market cap rose US$39m last week but individual investors profited the most - Simply Wall St
Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result - GuruFocus.com
LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency - The Manila Times
Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) Target Price at $12.00 - Defense World
Medifast Announces Third Quarter 2024 Financial Results - StockTitan
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Buy" by Brokerages - MarketBeat
LifeMD announces board member resignation By Investing.com - Investing.com Australia
LifeMD announces board member resignation - Investing.com India
LifeMD stock touches 52-week low at $4.03 amid market challenges - Investing.com Canada
LifeMD Shares Decline Even After the Launch of Testosterone Therapy - MSN
LifeMD® To Report Third Quarter 2024 Financial Results On November 7 - Barchart
LifeMD launches TestoRx, direct to consumer testosterone replacement therapy - Yahoo Finance
LifeMD® to Report Third Quarter 2024 Financial Results on November 7 - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering - Yahoo Finance
The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
Trading Day Review: LifeMD Inc (LFMD) Gains Momentum, Closing at 4.64 - The Dwinnex
LifeMD shares hold as BTIG maintains $12 target By Investing.com - Investing.com Australia
LifeMD shares hold as BTIG maintains $12 target - Investing.com
Is it possible to buy LifeMD Inc(LFMD) shares at a good price now? - US Post News
LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions - Yahoo Finance
LifeMD Inc [LFMD] stock for 14,790 USD was bought by Galluppi Stefan - Knox Daily
LifeMD Inc (LFMD) Stock: A Year of Declines and Increases - The InvestChronicle
Lifemd Inc Stock (LFMDP) Financials Data
There is no financial data for Lifemd Inc (LFMDP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
14.67%
0.78%
Cap:
|
Volume (24h):